Metagenomi Technologies, LLC News

Express News | HC Wainwright & Co. Reiterates Buy on Metagenomi, Maintains $10 Price Target

BenzingaMay 15 11:09 ET

Express News | Metagenomi Technologies LLC : Jefferies Cuts Target Price to $21 From $22

ReutersMay 15 02:01 ET

Express News | Metagenomi Q1 2024 Adj EPS $(1.19) Misses $(0.78) Estimate

BenzingaMay 14 16:39 ET

Express News | Metagenomi Inc: Cash Runway Anticipated to Support Anticipated Operating Plans Into 2027

ReutersMay 14 16:22 ET

Metagenomi Technologies, LLC | 10-Q: Quarterly report

SEC announcementMay 14 16:13 ET · Announcements

Press Release: Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results

Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results Late breaking presentation at World Federation of Hemophilia (WFH) World Congress on investigational develo

Dow JonesMay 14 16:05 ET

Metagenomi Price Target Announced at $10.00/Share by HC Wainwright & Co.

Metagenomi Price Target Announced at $10.00/Share by HC Wainwright & Co.

Dow JonesMay 7 06:20 ET

Express News | Metagenomi, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating

ReutersMay 7 06:09 ET

Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars

Thursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an income of $(0.19), smaller than the consensus estimate loss of $(3.55).The company reported sales of $167

BenzingaMay 2 13:12 ET

12 Health Care Stocks Moving In Thursday's Intraday Session

GainersEmergent BioSolutions (NYSE:EBS) stock moved upwards by 98.4% to $3.83 during Thursday's regular session. The company's market cap stands at $200.6 million. The company's, Q1 earnings came out

BenzingaMay 2 12:31 ET

Express News | Metagenomi Shares Are Trading Lower After Moderna and the Company Mutually Agreed to Terminate Their Collaboration on Primary Hyperoxaluria Type 1 and Rights to Develop the PH1 Program. Also, JP Morgan Downgraded the Stock From Overweight to Neutral and L

BenzingaMay 2 11:58 ET

Metagenomi Cut to Neutral From Overweight by JP Morgan

Metagenomi Cut to Neutral From Overweight by JP Morgan

Dow JonesMay 2 08:42 ET

Express News | JP Morgan Downgrades Metagenomi to Neutral, Lowers Price Target to $6

BenzingaMay 2 08:32 ET

Express News | Metagenomi Inc : Chardan Capital Markets Cuts Target Price to $17 From $21

ReutersMay 2 07:51 ET

Express News | Metagenomi Inc : JP Morgan Cuts Target Price to $6 From $16

ReutersMay 2 00:29 ET

Express News | Metagenomi Inc : JP Morgan Cuts to Neutral From Overweight

ReutersMay 2 00:29 ET

Metagenomi, Moderna Terminate Gene Editing Collaboration

Seeking AlphaMay 1 16:56 ET

Express News | Metagenomi Inc: Expects to Report That It Had About $327.4 Mln in Cash & Cash Equivalents as of March 31, 2024

ReutersMay 1 16:42 ET

Express News | Metagenomi: Under Termination Deal, Regained Full Development, Commercialization Rights to Wholly-Owned Base Editing, Rna-Mediated Integration Systems

ReutersMay 1 16:42 ET

Express News | Metagenomi Inc: On April 26, Co and Modernatx, Inc Mutually Terminated Strategic Collaboration and License Agreement Dated Oct 29, 2021

ReutersMay 1 16:40 ET